Most Recent

image: Speaking of Science

Speaking of Science

By | March 1, 2012

March 2012's selection of notable quotes

6 Comments

image: Electron Microscopy Through the Ages

Electron Microscopy Through the Ages

By | March 1, 2012

Take a tour through the revolutionary menthod's past, present, and future.

8 Comments

image: Promoting Death

Promoting Death

By | March 1, 2012

Editor's choice in biochemistry

0 Comments

image: The Specter of Denialism

The Specter of Denialism

By | March 1, 2012

Conspiracy theories surrounding the global HIV/AIDS epidemic have cost thousands of lives. But science is fighting back.

94 Comments

image: The Subcellular World Revealed, 1945

The Subcellular World Revealed, 1945

By | March 1, 2012

The first electron microscope to peer into an intact cell ushers in the new field of cell biology.

4 Comments

image: Ovarian Stem Cells in Humans?

Ovarian Stem Cells in Humans?

By | February 27, 2012

Adult human ovaries contain a population of stem cells capable of generating immature egg cells.

7 Comments

image: Climate Conflict of Interest?

Climate Conflict of Interest?

By | February 24, 2012

Greenpeace flags researchers' payments from a climate change skeptic organization.

0 Comments

image: New Kind of Cellular Suicide

New Kind of Cellular Suicide

By | February 23, 2012

Researchers identify a gene that drives a type of cellular suicide that differs from the more commonly observed apoptosis phenomenon.

0 Comments

image: Long Live the Y

Long Live the Y

By | February 22, 2012

Despite suggestions to the contrary, the Y chromosome is not necessarily rotting away.

8 Comments

image: Opinion: Good, But Not Good Enough

Opinion: Good, But Not Good Enough

By | February 22, 2012

Funding only outstanding researchers is increasing the gap between good and great labs and forcing some out of science in search of a bigger paycheck.

46 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham